89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,315 | -10,544 | -57,420 | -38,137 | -19,412 |
| Depreciation Amortization | 107 | 12 | 17 | 12 | 7 |
| Income taxes - deferred | N/A | N/A | 20 | -69 | -50 |
| Accounts payable and accrued liabilities | 2,123 | 3,066 | -520 | 1,610 | -541 |
| Other Working Capital | 1,529 | 2,287 | 937 | 2,625 | 702 |
| Other Operating Activity | -720 | -2,573 | 31,506 | 19,631 | 11,163 |
| Operating Cash Flow | $-19,276 | $-7,752 | $-25,460 | $-14,328 | $-8,131 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -107 | -61 | -139 | -28 | -20 |
| Purchase Of Investment | -5,698 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-5,805 | $-61 | $-139 | $-28 | $-20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 105 | 9 | 87,702 | 11 | 11 |
| Other Financing Activity | -161 | 0 | 20,000 | 19,314 | 18,826 |
| Financing Cash Flow | $-56 | $9 | $107,702 | $19,325 | $18,837 |
| Beginning Cash Position | 93,360 | 93,360 | 11,257 | 11,257 | 11,257 |
| End Cash Position | 68,223 | 85,556 | 93,360 | 16,226 | 21,943 |
| Net Cash Flow | $-25,137 | $-7,804 | $82,103 | $4,969 | $10,686 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,276 | -7,752 | -25,460 | -14,328 | -8,131 |
| Capital Expenditure | -107 | -61 | -139 | -28 | -20 |
| Free Cash Flow | -19,383 | -7,813 | -25,599 | -14,356 | -8,151 |